CUVL — Clinuvel Pharmaceuticals Ltd
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1290877 ·
Australia
Last close
$4.90
Market Cap
$247.39M
52W High
$8.87
52W Low
$4.81
ADV30
5,823
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 295,091,228 | 252,055,390 | 22,209,933 |
| Jun 2025 | — | — | — | — | 271,750,012 | 224,105,942 | 30,941,386 |
Balance + Analyst (yfinance extras)
Retained Earnings
$95,043,053
Inventory
$6,881,366
Receivables
$23,453,505
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$94,024,400
EBITDA
$41,108,156
Free Cash Flow
$25,389,714
Enterprise Value
$42,364,904
Total Cash
$252,055,392
Total Debt
$1,938,486
Shares Out
50,487,126
Trailing EPS
$0.45
Book Value
$3.78
ROE
13.2%
ROA
8.9%
Div Yield
0.63%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 94,024,398 | 39,546,095 | 33,916,819 | 295,091,228 | 22,209,933 | 272,881,295 | — |
| Jun 2025 | 95,017,570 | 45,733,209 | 36,172,518 | 271,750,012 | 30,941,386 | 240,808,626 | — |
| Jun 2024 | 88,178,308 | 48,005,841 | 35,636,359 | 231,123,549 | 28,112,183 | 203,011,366 | — |
| Jun 2023 | 78,321,318 | 44,102,498 | 30,604,566 | 193,713,556 | 29,082,413 | 164,631,143 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RMM | RiverNorth Managed Duration Municipal Income Fund, Inc. | $248.13M | $12.57 | — |
| CLVLF | Clinuvel Pharmaceuticals Ltd | $249.91M | $4.95 | — |
| OPTX | SYNTEC OPTICS HOLDINGS, INC. | $243.69M | $6.05 | — |
| IVAI | Ives Ultra AI Opportunities Inc. | $251.50M | $10.06 | — |
| CPZ | Calamos Long/Short Equity & Dynamic Income Trust | $241.87M | $12.32 | — |
News headlines (Yahoo Finance, 1h cache)
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
2026-08-27 05:42 · Yahoo
Vita Life Sciences And 2 Other Australian Biotech Stocks To Own
2026-11-14 16:08 · Yahoo
3 Great Australian Biotech Stocks To Own In November 2026
2026-11-07 15:14 · Yahoo
Vita Life Sciences And 2 Australian Biotech Stock Picks
2026-10-31 14:12 · Yahoo
3 Australian Biotech Stocks To Own In October 2026
2026-10-24 13:12 · Yahoo
Vita Life Sciences And 2 Other Australian Biotech Stocks To Watch
2026-10-17 12:15 · Yahoo
Top 3 Australian Biotech Stocks To Watch In October 2026
2026-10-10 11:14 · Yahoo
3 Great Australian Biotech Stocks With P E Under 14
2026-10-02 14:12 · Yahoo
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
2026-07-23 04:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.